Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Molkentine JM"'
Autor:
Thatikonda V; Boehringer Ingelheim RCV, Vienna, Austria. vthatikonda@exscientia.co.uk.; Exscientia, Vienna, Austria. vthatikonda@exscientia.co.uk., Lyu H; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jurado S; Boehringer Ingelheim RCV, Vienna, Austria., Kostyrko K; Boehringer Ingelheim RCV, Vienna, Austria., Bristow CA; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Albrecht C; Boehringer Ingelheim RCV, Vienna, Austria., Alpar D; Boehringer Ingelheim RCV, Vienna, Austria., Arnhof H; Boehringer Ingelheim RCV, Vienna, Austria., Bergner O; Boehringer Ingelheim RCV, Vienna, Austria., Bosch K; Boehringer Ingelheim RCV, Vienna, Austria., Feng N; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao S; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gerlach D; Boehringer Ingelheim RCV, Vienna, Austria., Gmachl M; Boehringer Ingelheim RCV, Vienna, Austria., Hinkel M; Boehringer Ingelheim RCV, Vienna, Austria., Lieb S; Boehringer Ingelheim RCV, Vienna, Austria., Jeschko A; Boehringer Ingelheim RCV, Vienna, Austria., Machado AA; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Madensky T; Boehringer Ingelheim RCV, Vienna, Austria., Marszalek ED; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahendra M; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Melo-Zainzinger G; Boehringer Ingelheim RCV, Vienna, Austria., Molkentine JM; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jaeger PA; Boehringer Ingelheim RCV, Vienna, Austria., Peng DH; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schenk RL; Boehringer Ingelheim RCV, Vienna, Austria., Sorokin A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Strauss S; Boehringer Ingelheim RCV, Vienna, Austria., Trapani F; Boehringer Ingelheim RCV, Vienna, Austria., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vellano CP; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Petronczki M; Boehringer Ingelheim RCV, Vienna, Austria., Kraut N; Boehringer Ingelheim RCV, Vienna, Austria., Heffernan TP; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Marszalek JR; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pearson M; Boehringer Ingelheim RCV, Vienna, Austria., Waizenegger IC; Boehringer Ingelheim RCV, Vienna, Austria., Hofmann MH; Boehringer Ingelheim RCV, Vienna, Austria. marco.hofmann@boehringer-ingelheim.com.
Publikováno v:
Nature cancer [Nat Cancer] 2024 Sep; Vol. 5 (9), pp. 1352-1370. Date of Electronic Publication: 2024 Aug 05.
Autor:
Vichaya EG; Department of Psychology & Neuroscience, Baylor University, Waco, TX 76798, USA. Electronic address: elisabeth_vichaya@baylor.edu., Darpolor JK; Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, TX 77030, USA., Gross PS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Molkentine JM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Vermeer DW; Cancer Biology Research Center, Sanford Research, Sioux Falls, SD 57104, USA., Vermeer PD; Cancer Biology Research Center, Sanford Research, Sioux Falls, SD 57104, USA., Lee JH; Avera Cancer Institute, 1000 E 23(rd) St., Sioux Falls, SD 57105, USA., Taniguchi CM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dantzer R; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Brain, behavior, and immunity [Brain Behav Immun] 2023 Jan; Vol. 107, pp. 296-304. Date of Electronic Publication: 2022 Oct 30.
Autor:
Garcia Garcia CJ; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center Houston, Texas; School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico., Huang Y; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fuentes NR; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Turner MC; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Monberg ME; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lin D; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nguyen ND; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fujimoto TN; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhao J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lee JJ; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bernard V; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center Houston, Texas; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yu M; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Delahoussaye AM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jimenez Sacarello I; School of Medicine, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico., Caggiano EG; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center Houston, Texas., Phan JL; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Deorukhkar A; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Molkentine JM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Saur D; Division of Translational Cancer Research, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany., Maitra A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Taniguchi CM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: ctaniguchi@mdanderson.org.
Publikováno v:
Gastroenterology [Gastroenterology] 2022 Jun; Vol. 162 (7), pp. 2018-2031. Date of Electronic Publication: 2022 Feb 22.
Autor:
Molkentine DP; Department of Radiation Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Molkentine JM; Department of Radiation Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Bridges KA; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Valdecanas DR; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Dhawan A; Department of Radiation Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Bahri R; Department of Radiation Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Hefner AJ; Department of Radiation Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Kumar M; Department of Biochemistry, AIMS, Bilaspur, Himachal Pradesh, India., Yang L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Abdelhakiem M; Department of Radiation Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Pifer PM; Department of Radiation Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Sandulache V; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston Texas., Sheth A; Department of Internal Medicine, Baylor College of Medicine, Houston Texas., Beadle BM; Department of Radiation Oncology, Stanford University, Stanford California., Thames HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mason KA; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pickering CR; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Meyn RE; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Skinner HD; Department of Radiation Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
Publikováno v:
Cancer research [Cancer Res] 2022 Mar 01; Vol. 82 (5), pp. 916-928.
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints.
Autor:
Molkentine JM; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Molkentine DP; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Bridges KA; Department of Experimental Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Xie T; Department of Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Yang L; Department of Experimental Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Sheth A; Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA., Heffernan TP; Institute for Applied Cancer Science, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Clump DA; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Faust AZ; College of Liberal Arts and Sciences, University of Illinois at Chicago, Chicago, IL, USA., Ferris RL; Department of Otolaryngology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Myers JN; Department of Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Frederick MJ; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX, USA., Mason KA; Department of Experimental Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Meyn RE; Department of Experimental Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Pickering CR; Department of Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Skinner HD; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Publikováno v:
International journal of radiation biology [Int J Radiat Biol] 2021; Vol. 97 (8), pp. 1121-1128. Date of Electronic Publication: 2020 Feb 25.
Autor:
Yu M; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nguyen ND; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Huang Y; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin D; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fujimoto TN; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Molkentine JM; Department of Radiation Oncology, University of Pittsburgh, Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Deorukhkar A; Department of Surgical Oncology., Kang Y; Department of Surgical Oncology., San Lucas FA; Department of Hematopathology., Fernandes CJ; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Koay EJ; Department of Radiation Oncology., Gupta S; Department of Pathology.; Department of Translational Molecular Pathology, and., Ying H; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Koong AC; Department of Radiation Oncology., Herman JM; Department of Radiation Oncology., Fleming JB; Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Maitra A; Department of Pathology.; Department of Translational Molecular Pathology, and., Taniguchi CM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Radiation Oncology.
Publikováno v:
JCI insight [JCI Insight] 2019 Jul 23; Vol. 5. Date of Electronic Publication: 2019 Jul 23.
Autor:
Fujimoto TN; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Huang Y; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Molkentine JM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Deorukhkar A; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Baseler L; Department of Veterinary Medicine & Surgery, UT MD Anderson Cancer Center, Houston, Texas., de la Cruz Bonilla; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yu M; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lin D; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gupta S; Department of Pathology, UT MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, Texas., Cabeceiras PK; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kingsley CV; Department of Imaging Physics, UT MD Anderson Cancer Center, Houston, Texas., Tailor RC; Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, Texas., Sawakuchi GO; Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, Texas., Koay EJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Piwnica-Worms H; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Maitra A; Department of Pathology, UT MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, Texas., Taniguchi CM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. ctaniguchi@mdanderson.org.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer research [Cancer Res] 2019 May 01; Vol. 79 (9), pp. 2327-2338.
Autor:
Molkentine JM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Fujimoto TN; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Horvath TD; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Grossberg AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America.; Department of Symptoms Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Garcia CJG; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Deorukhkar A; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., de la Cruz Bonilla M; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Lin D; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Samuel ELG; Department of Chemistry, Smalley-Curl Institute and the NanoCarbon Center, and Department of Materials Science and NanoEngineering, Rice University, Houston, Texas, United States of America., Chan WK; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Lorenzi PL; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Piwnica-Worms H; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Dantzer R; Department of Symptoms Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Tour JM; Department of Chemistry, Smalley-Curl Institute and the NanoCarbon Center, and Department of Materials Science and NanoEngineering, Rice University, Houston, Texas, United States of America., Mason KA; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America., Taniguchi CM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America. ctaniguchi@mdanderson.org.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America. ctaniguchi@mdanderson.org.
Publikováno v:
Scientific reports [Sci Rep] 2019 Feb 13; Vol. 9 (1), pp. 1949. Date of Electronic Publication: 2019 Feb 13.
Autor:
Grossberg AJ; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas. agrossberg@mdanderson.org.; Department of Symptom Research, MD Anderson Cancer Center, Houston, Texas., Vichaya EG; Department of Symptom Research, MD Anderson Cancer Center, Houston, Texas., Christian DL; Department of Symptom Research, MD Anderson Cancer Center, Houston, Texas., Molkentine JM; Department of Experimental Radiation Oncology, MD Anderson Cancer Center, Houston, Texas., Vermeer DW; Cancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota., Gross PS; Department of Symptom Research, MD Anderson Cancer Center, Houston, Texas., Vermeer PD; Cancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota., Lee JH; Cancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota., Dantzer R; Department of Symptom Research, MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer research [Cancer Res] 2018 Feb 01; Vol. 78 (3), pp. 695-705. Date of Electronic Publication: 2017 Dec 07.
Autor:
Vichaya EG; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 384, Houston, TX 77030, USA. Electronic address: egvichaya@mdanderson.org., Vermeer DW; Cancer Biology Research Center, Sanford Research, 2301 E. 60th St N, Sioux Falls, SD 57104, USA., Christian DL; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 384, Houston, TX 77030, USA., Molkentine JM; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 66, Houston, TX 77030, USA., Mason KA; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 66, Houston, TX 77030, USA., Lee JH; Cancer Biology Research Center, Sanford Research, 2301 E. 60th St N, Sioux Falls, SD 57104, USA; Chan Soon Shiong Institute of Molecular Medicine, 9920 Jefferson Blvd, Culver City, CA 90230, USA., Dantzer R; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 384, Houston, TX 77030, USA.
Publikováno v:
Psychoneuroendocrinology [Psychoneuroendocrinology] 2017 May; Vol. 79, pp. 59-66. Date of Electronic Publication: 2017 Feb 11.